Preeti Jois, Alexandre Mebazaa, Pupalan Iyngkaran, Merlin Thomas C, Claudio Ronco
Department of Nephrology Dialysis & Transplantation International Renal Research Institute (IRRIV) San Bortolo Hospital Viale Rodolfi, 37 36100 Vicenza, Italy.
Curr Cardiol Rev. 2016;12(3):186-94. doi: 10.2174/1573403x12666160606120958.
The most important advancements in the Cardiorenal syndrome (CRS) are its definition and subsequent classifications. When the predominant pathology and pathophysiology is the heart, i.e. chronic heart failure (CHF), and where any renal impairment (RI) subsequent to this is secondary, the classification is type 2 CRS. There are unique differences in the pathophysiology and progression of individual subclasses. It is important to understand the evolution of CHF and consequences of subsequent RI as they are becoming increasingly prevalent, aggravate morbidity and mortality and limit many therapeutic options. In this paper we discuss the significance of the type 2 CRS patients in the context of the thematic series.
心肾综合征(CRS)最重要的进展在于其定义及随后的分类。当主要的病理和病理生理过程源于心脏,即慢性心力衰竭(CHF),且在此之后出现的任何肾功能损害(RI)为继发性时,分类为2型CRS。各个亚类在病理生理和进展方面存在独特差异。了解CHF的演变以及随后RI的后果很重要,因为它们正变得越来越普遍,会加重发病率和死亡率,并限制许多治疗选择。在本文中,我们将在专题系列的背景下讨论2型CRS患者的意义。